Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: PPI-amoxicillin for H. Pylori Treatment [Phase 4]
Phase 4 clinical trial update for PPI-amoxicillin in treating Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Vonoprazan in Helicobacter Pylori Treatment an RCT [Phase 4]
A Phase 4 randomized trial assessing vonoprazan for Helicobacter pylori infection has completed.
-
FDA approval · 2021-07-07FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole). This approval supports updates to labeling and expan…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Efficacy of Probiotics in the Gut Microbiota and H Pylori Density [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update evaluating the efficacy of probiotics on gut microbiota and Helicobacter density has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication [Phase 4]
Phase 4 trial update evaluating vonoprazan as first-line treatment for Helicobacter pylori eradication, reporting on efficacy and safety.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days [Phase 4]
A Phase 4 randomized trial comparing 10- and 14-day bismuth-containing quadruple therapy for Helicobacter pylori eradication.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT [Phase 3]
Phase 3 pilot trial update of triple therapy including tegoprazan in Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies [Phase 4]
Phase 4 clinical trial comparing different bismuth quadruple therapies for Helicobacter pylori eradication in the context of gastric cancer …
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY [Phase 4]
Phase 4 trial evaluating the effect of Helicobacter pylori eradication therapy on gastric wall thickness prior to laparoscopic sleeve gastre…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Helicobacter Pylori Eradication With a New Sequential Treatment [Phase 3]
Phase 3 trial update on a new sequential treatment for Helicobacter pylori eradication completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial comparing sequential therapy to triple therapy for Helicobacter pylori eradication in adults, with placebo…
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Effectiveness of Rifabutin for Treatment of Helicobacter Pylori [Phase 3]
Phase 3 trial investigating the effectiveness of rifabutin for treatment of Helicobacter pylori infections.
-
FDA label_change · 2021-03-05FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination product Bismuth subcitrate potassium, metronidazole and tetracycline hydrochlori…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: 14-day Quadruple Therapy Versus Triple Therapy in HP Eradication [Phase 4]
A Phase 4 trial comparing 14-day quadruple therapy to triple therapy for Helicobacter pylori eradication in gastritis/H. pylori.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution [Phase 4]
Phase 4 trial update comparing intraluminal mono-antibiotic therapy using levofloxacin powder vs levofloxacin solution for Helicobacter pylo…
-
FDA approval · 2021-02-01FDA Approved: LANSOPRAZOLE — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's Original Application for a generic lansoprazole. Lansoprazole is a proton pump inhibitor used to treat pepti…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. [Phase 3]
Phase 3 trial comparing non-invasive test-guided tailored therapy to empiric treatment for Helicobacter pylori infection, focusing on antibi…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment [Phase 4]
Phase 4 trial update on bismuth-metronidazole triple therapy as first-line treatment for Helicobacter pylori infection.
-
FDA approval · 2020-12-10FDA Approved: OMEPRAZOLE — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for a generic omeprazole product (ANDA 212977) manufactured by Golden State Medical Supply, Inc.
-
FDA approval · 2020-12-09FDA Approved: OMEPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Omeprazole from Dr. Reddy's Laboratories Limited.
-
FDA label_change · 2020-11-27FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the labeli…
-
FDA approval · 2020-11-27FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Omeprazole from Quallent Pharmaceuticals Health LLC (a generic proton pump inhibitor).
-
FDA approval · 2020-11-27FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC. This action authorizes the salt form of esomepra…
-
FDA approval · 2020-11-27FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for omeprazole submitted by Aurobindo Pharma Limited (ANDA 203270), granting approval for a generi…
-
FDA approval · 2020-11-27FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Omeprazole from Sandoz Inc (ANDA075757). The approval confirms the generic product under the app…